“In April, an expert advisory panel for the FDA voted unanimously to recommend Epidiolex’s approval and determined that ‘CBD has a negligible abuse potential.’ The DEA did not immediately respond to Ars’ request for comment. But GW said it expects that the DEA will reschedule CBD within 90 days.”
Related posts:
No way out: Julian Assange marks one year inside Ecuadorian embassy in UK
Reality Check: Do We Really Need To Audit The Federal Reserve?
Secret account in mission-critical router opens power plants to tampering
Hemp flag to fly over the Capitol on the 4th of July
NWO: The Enemy of Humanity HD
Obamacare is About to Get More Personal
Bitcoin & Sneaks Law with Jeffrey Paul
130 Mexican Political Candidates Assassinated in 10 Months
What Will ObamaCare Cost You, Beginning on January 1? Do You Know?
French agency caught minting SSL certificates impersonating Google
Bitcoin Becomes a Real Job and Wall Street Is Hiring
Snowden plans to settle and work in Russia – lawyer to RT
Redacted FBI Documents Show Plot to Kill Occupy Leaders If ‘Deemed Necessary’
Beating Obamacare: Hospitals Across Borders
Man With Down Syndrome Killed By Police Over $11 Movie Ticket